Compare Philip Morris International Inc. (PM) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Philip Morris International Inc. vs Tilray Brands Inc — how do they compare? Philip Morris International Inc. trades at $195 (market cap $293.07B), while Tilray Brands Inc trades at $4.2 (market cap $524.07M). The key difference: Philip Morris International Inc. is far larger — about 559.2× Tilray Brands Inc's market cap, and Philip Morris International Inc. pays a 3.13% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| PM | TLRY | |
|---|---|---|
Market Cap | $293.07B | $524.07M |
Sector | Consumer Staples | Health |
52-Week High | $192.98 | $21.00 |
52-Week Low | $144.33 | $4.23 |
Enterprise Value | $339.57B | $621.22M |
Dividend Yield | 3.13% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Philip Morris International (PM) trades at $192.72, down 0.13% on the day, with strong analyst support (17 buy ratings) and a $194 consensus price target. The stock shows bullish technical momentum above key support levels, while fundamentals reveal robust profitability with 26.74% net margins and consistent revenue growth to $40.65B in 2025. Recent news includes a profit forecast revision due to a $500M impairment charge and CFO succession planning.
PM offers stable dividend income and brand strength but faces headwinds from cost pressures and illicit market growth. The stock trades at a premium valuation (P/E 27.13) with elevated debt levels, requiring monitoring of pricing power and regulatory developments. Near-term catalysts include Q2 earnings and execution of the smoke-free transition strategy.
TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.
The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
